Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 12 studies | 48% ± 21% | |
endothelial cell | 12 studies | 42% ± 15% | |
fibroblast | 7 studies | 32% ± 17% | |
ciliated cell | 7 studies | 43% ± 19% | |
vein endothelial cell | 5 studies | 44% ± 22% | |
adipocyte | 4 studies | 24% ± 5% | |
endothelial cell of artery | 4 studies | 40% ± 24% | |
club cell | 4 studies | 25% ± 9% | |
endothelial cell of vascular tree | 3 studies | 24% ± 8% | |
endothelial cell of lymphatic vessel | 3 studies | 23% ± 4% | |
respiratory goblet cell | 3 studies | 33% ± 10% | |
oligodendrocyte | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 741.03 | 245 / 245 | 99% | 10.19 | 499 / 502 |
intestine | 100% | 547.40 | 963 / 966 | 88% | 7.31 | 463 / 527 |
thymus | 100% | 1356.00 | 653 / 653 | 86% | 15.14 | 522 / 605 |
breast | 98% | 311.57 | 452 / 459 | 76% | 8.79 | 853 / 1118 |
lung | 100% | 1072.34 | 578 / 578 | 74% | 9.90 | 852 / 1155 |
kidney | 100% | 852.47 | 89 / 89 | 68% | 6.08 | 610 / 901 |
bladder | 100% | 742.67 | 21 / 21 | 64% | 6.34 | 323 / 504 |
stomach | 72% | 338.84 | 258 / 359 | 82% | 6.12 | 234 / 286 |
brain | 80% | 484.68 | 2101 / 2642 | 74% | 4.12 | 520 / 705 |
esophagus | 95% | 353.74 | 1367 / 1445 | 54% | 3.73 | 98 / 183 |
adrenal gland | 96% | 250.97 | 247 / 258 | 52% | 5.53 | 119 / 230 |
uterus | 99% | 1354.50 | 169 / 170 | 41% | 4.85 | 187 / 459 |
pancreas | 47% | 68.33 | 154 / 328 | 87% | 5.66 | 154 / 178 |
liver | 96% | 252.82 | 217 / 226 | 35% | 1.45 | 142 / 406 |
ovary | 100% | 632.14 | 180 / 180 | 13% | 0.62 | 57 / 430 |
spleen | 100% | 756.81 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 392.85 | 1194 / 1204 | 0% | 0 | 0 / 0 |
heart | 72% | 223.38 | 624 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 71% | 163.48 | 942 / 1335 | 0% | 0 | 0 / 0 |
skin | 38% | 61.40 | 682 / 1809 | 29% | 3.99 | 136 / 472 |
lymph node | 0% | 0 | 0 / 0 | 66% | 2.84 | 19 / 29 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.66 | 6 / 45 |
muscle | 10% | 13.89 | 78 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.13 | 3 / 80 |
peripheral blood | 0% | 0.78 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
GO_0001508 | Biological process | action potential |
GO_0060158 | Biological process | phospholipase C-activating dopamine receptor signaling pathway |
GO_0005834 | Cellular component | heterotrimeric G-protein complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0031683 | Molecular function | G-protein beta/gamma-subunit complex binding |
GO_0005525 | Molecular function | GTP binding |
GO_0003924 | Molecular function | GTPase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
Gene name | GNA14 |
Protein name | Guanine nucleotide-binding protein subunit alpha-14 (G alpha-14) (G-protein subunit alpha-14) |
Synonyms | |
Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. |
Accessions | O95837 ENST00000341700.7 |